BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30629237)

  • 1. Predictive Value of Cellular Accumulation of Hydrophobic Bile Acids As a Marker of Cholestatic Drug Potential.
    Burban A; Sharanek A; Humbert L; Eguether T; Guguen-Guillouzo C; Rainteau D; Guillouzo A
    Toxicol Sci; 2019 Apr; 168(2):474-485. PubMed ID: 30629237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive and Preferential Cellular Accumulation of Hydrophobic Bile Acids Induced by Cholestatic Drugs Is Associated with Inhibition of Their Amidation and Sulfation.
    Sharanek A; Burban A; Humbert L; Guguen-Guillouzo C; Rainteau D; Guillouzo A
    Drug Metab Dispos; 2017 Dec; 45(12):1292-1303. PubMed ID: 28928138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular Accumulation and Toxic Effects of Bile Acids in Cyclosporine A-Treated HepaRG Hepatocytes.
    Sharanek A; Burban A; Humbert L; Bachour-El Azzi P; Felix-Gomes N; Rainteau D; Guillouzo A
    Toxicol Sci; 2015 Oct; 147(2):573-87. PubMed ID: 26198044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The profile of bile acids and their sulfate metabolites in human urine and serum.
    Bathena SP; Mukherjee S; Olivera M; Alnouti Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 942-943():53-62. PubMed ID: 24212143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From the Cover: MechanisticInsights in Cytotoxic and Cholestatic Potential of the Endothelial Receptor Antagonists Using HepaRG Cells.
    Burbank MG; Sharanek A; Burban A; Mialanne H; Aerts H; Guguen-Guillouzo C; Weaver RJ; Guillouzo A
    Toxicol Sci; 2017 Jun; 157(2):451-464. PubMed ID: 28369585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Alterations of Bile Canaliculi Dynamics and the Rho Kinase/Myosin Light Chain Kinase Pathway Are Characteristics of Drug-Induced Intrahepatic Cholestasis.
    Burbank MG; Burban A; Sharanek A; Weaver RJ; Guguen-Guillouzo C; Guillouzo A
    Drug Metab Dispos; 2016 Nov; 44(11):1780-1793. PubMed ID: 27538918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of BSEP Function in HepaRG Cells Alters Bile Acid Disposition and Is a Susceptive Factor to Drug-Induced Cholestatic Injury.
    Qiu X; Zhang Y; Liu T; Shen H; Xiao Y; Bourner MJ; Pratt JR; Thompson DC; Marathe P; Humphreys WG; Lai Y
    Mol Pharm; 2016 Apr; 13(4):1206-16. PubMed ID: 26910619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional human induced hepatocytes (hiHeps) with bile acid synthesis and transport capacities: A novel in vitro cholestatic model.
    Ni X; Gao Y; Wu Z; Ma L; Chen C; Wang L; Lin Y; Hui L; Pan G
    Sci Rep; 2016 Dec; 6():38694. PubMed ID: 27934920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obeticholic acid protects against lithocholic acid-induced exogenous cell apoptosis during cholestatic liver injury.
    Lu Q; Zhu Y; Wang C; Zhang R; Miao Y; Chai Y; Jiang Z; Yu Q
    Life Sci; 2024 Jan; 337():122355. PubMed ID: 38104861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity and intracellular accumulation of bile acids in sandwich-cultured rat hepatocytes: role of glycine conjugates.
    Chatterjee S; Bijsmans IT; van Mil SW; Augustijns P; Annaert P
    Toxicol In Vitro; 2014 Mar; 28(2):218-30. PubMed ID: 24211540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunct Fenofibrate Up-regulates Bile Acid Glucuronidation and Improves Treatment Response For Patients With Cholestasis.
    Gallucci GM; Trottier J; Hemme C; Assis DN; Boyer JL; Barbier O; Ghonem NS
    Hepatol Commun; 2021 Dec; 5(12):2035-2051. PubMed ID: 34558841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Setup and Use of HepaRG Cells in Cholestasis Research.
    Guguen-Guillouzo C; Guillouzo A
    Methods Mol Biol; 2019; 1981():291-312. PubMed ID: 31016662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
    Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
    Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bile duct ligation on bile acid composition in mouse serum and liver.
    Zhang Y; Hong JY; Rockwell CE; Copple BL; Jaeschke H; Klaassen CD
    Liver Int; 2012 Jan; 32(1):58-69. PubMed ID: 22098667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine 1-phosphate receptor-1 specific agonist SEW2871 ameliorates ANIT-induced dysregulation of bile acid homeostasis in mice plasma and liver.
    Yang T; Wang X; Yuan Z; Miao Y; Wu Z; Chai Y; Yu Q; Wang H; Sun L; Huang X; Zhang L; Jiang Z
    Toxicol Lett; 2020 Oct; 331():242-253. PubMed ID: 32579994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Troglitazone Inhibits Bile Acid Amidation: A Possible Risk Factor for Liver Injury.
    Ogimura E; Nakagawa T; Deguchi J; Sekine S; Ito K; Bando K
    Toxicol Sci; 2017 Aug; 158(2):347-355. PubMed ID: 28486596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro assay to assess transporter-based cholestatic hepatotoxicity using sandwich-cultured rat hepatocytes.
    Ansede JH; Smith WR; Perry CH; St Claire RL; Brouwer KR
    Drug Metab Dispos; 2010 Feb; 38(2):276-80. PubMed ID: 19910518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative profiling of 19 bile acids in rat plasma, liver, bile and different intestinal section contents to investigate bile acid homeostasis and the application of temporal variation of endogenous bile acids.
    Yang T; Shu T; Liu G; Mei H; Zhu X; Huang X; Zhang L; Jiang Z
    J Steroid Biochem Mol Biol; 2017 Sep; 172():69-78. PubMed ID: 28583875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both cholestatic and steatotic drugs trigger extensive alterations in the mRNA level of biliary transporters in rat hepatocytes: Application to develop new predictive biomarkers for early drug development.
    Donato MT; López-Riera M; Castell JV; Gómez-Lechón MJ; Jover R
    Toxicol Lett; 2016 Nov; 263():58-67. PubMed ID: 27765674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lignans from Schisandra sphenanthera protect against lithocholic acid-induced cholestasis by pregnane X receptor activation in mice.
    Fan S; Liu C; Jiang Y; Gao Y; Chen Y; Fu K; Yao X; Huang M; Bi H
    J Ethnopharmacol; 2019 Dec; 245():112103. PubMed ID: 31336134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.